ABILIFY 10 mg orodispersible tablets

Each orodispersible tablet contains 10 mg of aripiprazole.

Excipient with known effect: 2 mg aspartame (E951) and 0.075 mg lactose per orodispersible tablet

For the full list of excipients, see section 6.1.

Orodispersible tablet

Round and pink, marked with "A" over "640" on one side and "10" on the other.

ABILIFY is indicated for the treatment of schizophrenia in adults and in adolescents aged 15 years and older.

ABILIFY is indicated for the treatment of moderate to severe manic episodes in Bipolar I Disorder and for the prevention of a new manic episode in adults who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment (see section 5.1).

ABILIFY is indicated for the treatment up to 12 weeks of moderate to severe manic episodes in Bipolar I Disorder in adolescents aged 13 years and older (see section 5.1).